FDA Approves Return of Popular Primatene Mist Asthma Inhaler

thumbnail

Trending Keywords   Epinephrine • Inhaler • Asthma • Metered-dose inhaler • Food and Drug Administration


FDA Approves Return of Popular Primatene Mist Asthma Inhaler U.S. News & World Report

TRENTON, N.J. (AP) — A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It's for temporary relief of mild, ...

Primatene non-prescription asthma inhaler back after 7 years NBCNews.com

The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for seven years, the Food and Drug Administration said Thursday. It will be the first time consumers can buy an asthma inhaler without a ...

Salmonella Tied to Turkey Sickens 164 in 35 States WebMD

Nov. 8, 2018 -- According to the U.S. Centers for Disease Control and Prevention, the total number of illnesses in a salmonella outbreak linked with raw turkey products now stands at 164 people across 35 states. That's 74 more cases than at the last ...

Primatene Mist Returns After 7-Year Absence MedPage Today

WASHINGTON -- Primatene Mist, the over-the-counter epinephrine inhaler for quick asthma relief, can go back on the market in a reformulated version, the FDA said Thursday. Now using a hydrofluoroalkane (HFA) propellant in place of the banned ...

OTC Asthma Inhaler to Return to Market After Seven Years Regulatory Focus

The US Food and Drug Administration (FDA) on Wednesday approved Amphastar Pharmaceuticals' Primatene Mist (epinephrine inhalation aerosol spray) metered-dose inhaler for over-the-counter (OTC) use to treat mild asthma, making it the first OTC ...

FDA reapproves OTC Primatene Mist for mild asthma Healio

The FDA has approved over-the-counter Primatene Mist to temporarily relieve symptoms of mild, intermittent asthma in patients aged 12 years and older, according to a press release. In the United States, Primatene Mist (epinephrine inhalation aerosol ...

Manage Your Asthma: Know Your Triggers and Treatment Options FDA.gov

Subscribe: FDA Consumer Health Information. Asthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of an asthma attack can include coughing, wheezing (a whistling sound when you breathe), chest tightness, ...

FDA Approves Return of Primatene Mist Asthma Inhaler WDIO

Created: November 08, 2018 04:16 PM. LINDA A. JOHNSON, AP Medical Writer. Advertisement – Content Continues Below. TRENTON, N.J. (AP) - A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and ...

Stocks mixed…Fed leaves key rate unchanged…Mortgage rates highest in 7 years KOAA.com Colorado Springs and Pueblo News

NEW YORK (AP) — Stock indexes are mixed in afternoon trading on Wall Street following yesterday's rally. The Dow Jones Industrial Average was slightly higher and the S&P 500 index and the Nasdaq composite slightly lower. Technology companies are ...

Health Highlights: Nov. 8, 2018 HealthDay

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: 164 People in 35 States Sickened in Salmonella Outbreak Linked to Raw Turkey. Just ahead of Thanksgiving, federal health officials have bad news for ...

Related Tweets

RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
RT @NBCNightlyNews: The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for…
The once-popular non-prescription asthma inhaler Primatene Mist can go back on the market after having been banned for seven years, the Food and Drug Administration said Thursday. https://t.co/1JlGVsTs2F
RT @asthma_bio: Dupixent Boosts Sanofis Third Quarter Which Also Benefits Regeneron: Nearly two weeks after the U.S. Food and Drug Administ…
Dupixent Boosts Sanofis Third Quarter Which Also Benefits Regeneron: Nearly two weeks after the U.S. Food and Drug Administration approved Sanofi and Regenerons Dupixent as an addon maintenance therapy for moderate to severe asthma the Francebased… https://t.co/XTGQVtELaP
Currently showing only Tweets for US stories